NCT07234604Not yet recruiting
Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?
Source: ClinicalTrials.gov · Last updated 24 Nov 2025
Brief summary (registry, in English)
To assess the RELIABILITY in terms of accuracy of 3D-CT and 2D-CT reconstructions compared to intraoperative data regarding bronchovascular anatomy and tumor location. 3D CT reconstruction (CT scan without contrast injection) with Innersight3D® is equivalent to 2D CT (CT scan with contrast injection) for planning a minimally invasive lung segmentectomy. Evaluate the impact of 3D reconstruction (from a CT scan without injection of contrast agent) on intraoperative and postoperative results
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 14 Nov 2025
- Start date
- Dec 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- University Hospital, Strasbourg, France
- Diseases
- Lung cancer
- NCT number
- NCT07234604
What you commit to
- Study type: Observational
- Planned participants: 50
- From Dec 2025 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergic reactions to radiographic contrast agents
- History of ipsilateral cardiothoracic surgery
- Severe cognitive impairment and/or suspicion of lack of compliance or adherence, in the investigator's judgment
Other
- Patient refusal to participate in the study
- Open segmentectomy (thoracotomy)
- Histology different from that of NSCLC
- Inability to provide the subject with informed information (difficulty understanding the subject, insufficient command of French, etc.)
- Pregnant or breastfeeding women
Who the study is looking for
- Adult patient ≥ 18 years
- Patient agreeing to participate in the study
- Patient with clinical stage IA lung lesions ≤ 2 cm in diameter AND a suspected or proven malignancy.
- Chest CT scan available without and then with contrast
- Eligible for VATS or RATS segmentectomy based on respiratory explorations
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service Chirurgie Thoracique - CHU de Strasbourg - France Coordinator of this site? Confirm its status | Strasbourg | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.